Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab

Published:2016-06-17 Issue:2 Volume:87 Page:141-147
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

de Flon Pierre,Gunnarsson Martin,Laurell Katarina,Söderström Lars,Birgander Richard,Lindqvist Thomas,Krauss Wolfgang,Dring Ann,Bergman Joakim,Sundström Peter,Svenningsson Anders

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study;European Journal of Neurology;2024-05-25

2. High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS;JAMA Neurology;2024-05-01

3. Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis;Multiple Sclerosis Journal;2024-01-02

4. Clinical efficacy of anti-CD20 antibodies in autoimmune diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. Disease‐modifying therapies in multiple sclerosis: A focused review of rituximab;Basic & Clinical Pharmacology & Toxicology;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP